Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. (Record no. 24372529)

MARC details
000 -LEADER
fixed length control field 02323 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517003242.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201508s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1569-8041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/annonc/mdu496
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Van Cutsem, E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150824
245 00 - TITLE STATEMENT
Title Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of oncology : official journal of the European Society for Medical Oncology
Date of publication, distribution, etc. Jan 2015
300 ## - PHYSICAL DESCRIPTION
Extent 149-156 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenocarcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Capecitabine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Docetaxel
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxaliplatin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stomach Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Taxoids
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boni, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tabernero, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Massuti, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Middleton, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dane, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reichardt, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pimentel, F L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cohn, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Follana, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clemens, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zaniboni, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moiseyenko, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Harrison, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Richards, D A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Prenen, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pernot, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ecstein-Fraisse, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hitier, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rougier, P
773 0# - HOST ITEM ENTRY
Title Annals of oncology : official journal of the European Society for Medical Oncology
Related parts vol. 26
-- no. 1
-- p. 149-156
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/annonc/mdu496">https://doi.org/10.1093/annonc/mdu496</a>
Public note Available from publisher's website

No items available.